Wall Street’s Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

In This Article:

If you’re looking for Wall Street’s favorite cannabis stocks, you’re most likely to find them amongst the holdings of the AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), the largest U.S.-listed cannabis exchange traded fund (ETF). MSOS is an actively managed ETF with just under $1 billion in net assets. Its net assets are more than four times those of the next largest fund, Amplify Alternative Harvest ETF (NYSEARCA:MJ), with $243 million in net assets.

If you’ve held MSOS since its launch in September 2020, you’ve got little to cheer about. In 2021, its total return was -29.7%, followed by a 2022 total return of -72.7% and 0.29% in 2023. The good news is that it’s up more than 32% in 2024, including 23% in the five trading days between March 13 and March 19. What is going on?

On March 15, Vice President Kamala Harris called on the U.S. Drug Enforcement Agency (DEA) to quickly decide the question of cannabis rescheduling from a Schedule 1 to a Schedule 3 drug, moving it one step closer to legalization.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Based on the good news, here are three of Wall Street’s favorite cannabis stocks to buy now. All three are holdings of the AdvisorShares Pure US Cannabis ETF.

Green Thumb Industries (GTBIF)

Forget a 1-for-12 Split, Aurora Stock May as Well Go for 200
Forget a 1-for-12 Split, Aurora Stock May as Well Go for 200

Source: Shutterstock

Green Thumb Industries (OTCMKTS:GTBIF) is the largest holding of the ETF, with a portfolio weight of 25.6%. Of the 17 analysts covering its stock, 15 rate it a Buy, with a target price of $16.29, 23% higher than its current price. GTBIF stock is up nearly 23% year-to-date (YTD).

Green Thumb was founded in 2014 and its products include RYTHM flower, Dogwalkers pre-rolls, Incredibles edibles and others. In addition to 20 manufacturing facilities, it operates 92 RISE retail locations in 14 U.S. markets. In 2023, its sales grew by 4% to $1.1 billion, with adjusted EBITDA of $326 million. On a GAAP basis, it earned $36 million.

“We ended the year with a strong balance sheet including $162 million in cash, net of $65 million returned to shareholders via share buybacks and debt repurchases,” CEO and founder Ben Kovler said in its Q4 2023 press release.

Cash flow was so good in 2023 that it repurchased $39.9 million of its stock last year at an average price of $10.50, well below where it’s currently trading.

Curaleaf Holdings (CURLF)

cannabis stocks, With America Turning Green Things Only Can Get Better for Aurora Stock
cannabis stocks, With America Turning Green Things Only Can Get Better for Aurora Stock

Source: Shutterstock

Curaleaf Holdings (OTCMKTS:CURLF) is the second-largest of MSOS’ holdings, with a portfolio weight of 19.93%. Fourteen analysts cover its stock, with 11 rating it a Buy and a target price of $5.91, 20% higher than its current price. CURLF stock is up nearly 23% YTD.